KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to 0.74.

  • Resmed's Equity Ratio rose 105.5% to 0.74 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.74, marking a year-over-year increase of 105.5%. This contributed to the annual value of 0.73 for FY2025, which is 315.11% up from last year.
  • Latest data reveals that Resmed reported Equity Ratio of 0.74 as of Q4 2025, which was up 105.5% from 0.74 recorded in Q3 2025.
  • Over the past 5 years, Resmed's Equity Ratio peaked at 0.74 during Q4 2025, and registered a low of 0.56 during Q4 2022.
  • Over the past 5 years, Resmed's median Equity Ratio value was 0.66 (recorded in 2022), while the average stood at 0.67.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 1809.88% in 2021, then plummeted by 1572.64% in 2022.
  • Resmed's Equity Ratio (Quarter) stood at 0.66 in 2021, then dropped by 15.73% to 0.56 in 2022, then rose by 15.92% to 0.65 in 2023, then rose by 13.33% to 0.74 in 2024, then rose by 1.05% to 0.74 in 2025.
  • Its Equity Ratio was 0.74 in Q4 2025, compared to 0.74 in Q3 2025 and 0.73 in Q2 2025.